 |  | |
 |
|
| Educational background |
| |
Ph.D., University of Michigan, 1995
|
|
| Research interests |
| |
Bioequivalence, time series, clinical research |
|
| Areas of expertise |
| |
| Pharmacokinetics | Models, Statistical |
| Models, Biological | Therapeutic Equivalency |
| Clinical Trials as Topic | Asthma |
| Statistics as Topic | Analysis of Variance |
| Data Interpretation, Statistical | Regression Analysis |
| Statistical Distributions | Controlled Clinical Trials as Topic |
| Breast Neoplasms | Decision Making, Computer-Assisted |
| Genetic Screening | Amantadine |
| Hepatitis C, Chronic | Eflornithine |
| Enzyme Inhibitors | Lung Neoplasms |
| Mammary Neoplasms, Experimental | Neoplasm Recurrence, Local |
| Antineoplastic Agents | Polyamines |
| Brain Injuries | Heredodegenerative Disorders, Nervous System |
| Hypoxia-Ischemia, Brain | Receptors, Interleukin-1 |
| Recovery of Function | Adaptor Proteins, Signal Transducing |
| Antigens, CD30 | Lymphoma, Large-Cell, Anaplastic |
| Lymphomatoid Papulosis | Skin Neoplasms |
| Genetic Counseling | Patient Education as Topic |
| Software | Blood Glucose |
| Diabetes Mellitus, Type 1 | Eating |
| Hypoglycemic Agents | Insulin |
| Insulin Infusion Systems | Electronic Mail |
| Physician-Patient Relations | Carrier Proteins |
| Drosophila Proteins | Mutation, Missense |
| Ovarian Neoplasms | Receptors, Transforming Growth Factor beta |
| Neoplasm Metastasis | Blood Pressure |
| Diabetes Complications | Diabetes Mellitus, Type 2 |
| Cross-Over Studies | Randomized Controlled Trials as Topic |
| Research Design | Wounds and Injuries |
|
|
| Publication author name |
|
|
|
|
|
